Drug development should prioritize speed to market to benefit patients while utilizing artificial intelligence as a supportive co-pilot rather than a replacement for physical lab experiments.

“the idea that you're going to throw on you know turn a switch on a computer and it's going to think about something and invent you know the next Prozac I don't know I I think we're a long way from that day yeah but we we're paying attention to all of it”